Printer Friendly

United Therapeutics Corporation passes Health Canada's approval for Unituxin for treating neuroblastoma.

Global Banking News-November 30, 2018-United Therapeutics Corporation passes Health Canada's approval for Unituxin for treating neuroblastoma

(C)2018 ENPublishing - http://www.enpublishing.co.uk

Biotechnology company United Therapeutics Corporation (NASDAQ:UTHR) reported on Thursday the receipt of the Health Canada's approval for the combination of Unituxin (dinutuximab for injection), granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2) and 13-cis-retinoic acid (RA), for neuroblastoma.

The company stated the PrUnituxin (dinutuximab for injection), in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), is authorised for the treatment of high-risk neuroblastoma in pediatric patients who achieve at least a partial response to prior first-line multiagent, multimodality therapy.

Earlier in 2017, Unituxin was approved by the US Food and Drug Administration, added the company.

According to the company, Unituxin is a GD2-binding monoclonal antibody indicated, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA) for high-risk neuroblastoma.

Neuroblastoma is a cancer often found in the small glands on top of the kidneys (adrenal glands). It can develop in the stomach, chest, neck, pelvis and bones. Children aged five or younger are commonly affected. Symptoms may include fatigue, loss of appetite and fever. There may be a lump or compression of tissues in the affected area.

((Distributed via M2 Communications - http://www.m2.com))

COPYRIGHT 2018 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Global Banking News (GBN)
Geographic Code:1CANA
Date:Nov 30, 2018
Words:215
Previous Article:KKR names several new managing directors for KKR Capstone and KKR.
Next Article:Sweco's conversion of shares registered by Swedish Companies Registration Office.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters